Malignant Hypertension–Induced Thrombotic Microangiopathy Mimicking Atypical Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura
Malignant hypertension is an important cause of secondary TMA. Controlled blood pressure reduction is the cornerstone of therapy. Multidisciplinary collaboration with nephrology helps confirm the diagnosis and guide plasma exchange decisions.
Authors
- Sumesh Khanal (ORCID: https://orcid.org/0000-0002-9681-1101)
- María Eugenia Acosta (ORCID: https://orcid.org/0000-0003-0801-4397)
- Miguel Quintanilla (ORCID: https://orcid.org/0000-0002-2124-7657)
- Michelle Carrasquel-Alvarez
- Mariana Valdez-Thomas
- Ynsnardy Jose Hurtado-Leon
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- McLaren Greater Lansing (US)
- Michigan State University (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-11-17
- DOI
- https://doi.org/10.1016/j.jaccas.2025.106031
- Citations
- 1
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.80